Article Information
History
- November 3, 2021.
Article Versions
- Version 1 (April 20, 2021 - 09:40).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Luca Miglietta1,2,
- Ahmad Moniri2,
- Ivana Pennisi1,
- Kenny Malpartida-Cardenas2,
- Hala Abbas3,
- Kerri Hill-Cawthorne1,
- Frances Bolt1,
- Elita Jauneikaite1,4,
- Frances Davies1,3,
- Alison Holmes1,3,
- Pantelis Georgiou2 and
- Jesus Rodriguez-Manzano1,*
- 1Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, UK
- 2Department of Electrical and Electronic Engineering, Faculty of Engineering, Imperial College London, London, UK
- 3Imperial College Healthcare NHS Trust, London, UK
- 4Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, UK
- ↵*Correspondence to:
Jesus Rodriguez-Manzano, PhD, Department of Infectious Disease, Imperial College London, Room 8N9, Commonwealth Building, Hammersmith Hospital Campus, Du Cane Road, London, W12 0NN; j.rodriguez-manzano{at}imperial.ac.uk
Posted November 03, 2021.
Coupling machine learning and high throughput multiplex digital PCR enables accurate detection of carbapenem-resistant genes in clinical isolates
